FDA Grants Regular Approval for Imatinib Mesylate Tablets

FDA Updates; 01/31/2012

The U.S. Food and Drug Administration (FDA) granted regular approval for imatinib mesylate tablets (Gleevec®, Novartis Pharmaceuticals) for the adjuvant treatment of adult patients following complete gross resection of Kit (CD117) positive Gastrointestinal Stromal Tumors (GIST).

The FDA Approves Vismodegib for Metastatic Basal Cell Carcinoma

FDA Updates; 01/30/2012

The U.S. Food and Drug Administration approved vismodegib (ERIVEDGE™ Capsule, Genentech, Inc.) for the treatment of adults with metastatic basal cell carcinoma or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery, and who are not candidates for radiation.

FDA Approves Axitinib Tablets for Advanced Renal Cell Carcinoma

FDA Updates; 01/27/2012

The U.S. Food and Drug Administration approved axitinib tablets (Inlyta, Pfizer, Inc.) for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy.

ONS Wins 2011 AJN Book of the Year Award

ONS News; 01/26/2012

The American Journal of Nursing (AJN) has awarded the prestigious 2011 AJN Book of the Year Award to the Oncology Nursing Society (ONS) for Advanced Oncology Nursing Certification Review and Resource Manual: Instructor’s Resource, edited by Shirley Triest-Robinson, RN, PhD, AOCNS®, ACNS B, and Wendy H. Vogel, MSN, FNP, AOCNP®, in the Electronic Media category.

Oncology Nursing Society Announces Anne Katz as Oncology Nursing Forum Editor

ONS News; 01/25/2012

The Oncology Nursing Society (ONS) is pleased to announce Anne Katz, RN, PhD, as the new editor of the Oncology Nursing Forum (ONF), the Society’s flagship journal. Katz will begin her new responsibility on March 1.

United States Senate Passes a Resolution Recognizing the 40th Anniversary of the National Cancer Act

Legislative Updates; 01/19/2012

A resolution recognizing the 40th anniversary of the National Cancer Act of 1971 and the more than 12,000,000 survivors of cancer alive today because of the commitment of the United States to cancer research and advances in cancer prevention, detection, diagnosis, and treatment.

FDA Approves Glucarpidase Injection

FDA Updates; 01/17/2012

The US Food and Drug Administration approved glucarpidase injection (Voraxaze®, BTG International Inc.) for the treatment of toxic plasma methotrexate concentrations (> 1 µmol/L) in patients with delayed methotrexate clearance due to impaired renal function.

FDA Approves Changes to Methotrexate Package Insert

FDA Updates; 12/21/2011

The US Food and Drug Administration has approved changes to the package inserts for methotrexate products for intravenous administration.

ONS Hosts Health Information Technology Think Tank

ONS News; 12/15/2011

The Oncology Nursing Society (ONS) recently hosted a groundbreaking HIT Think Tank in Pittsburgh, PA, to assess ways to support their members as HIT becomes more a part of everyday life in healthcare organizations.

ONS Congratulates Lt. General Horoho

Legislative Updates; 12/14/2011

ONS congratulates Lt. General Horoho on her confirmation as the newest Surgeon General of the US Army.